FWD 2 Commission E: Stinging Nettle root

  The Commission E Monographs

Stinging Nettle root


Urticae radix
Brennesselwurzel
Published September 18, 1986; Revised March 2, 1989, March 13, 1990, and January 17, 1991

Name of Drug

Urticae radix, nettle root, stinging nettle root.  

Composition of Drug

Stinging nettle root consists of the underground parts of Urtica dioica L., U. urens L.  and/or their hybrids [Fam.  Urticaceae] as well as preparations from nettle root at an effective dose.  

The drug contains -sitosterol in free forms and as glycosides, as well as scopoletin.  

Uses

Difficulty in urination in benign prostatic hyperplasia stages 1 and 2.  

Contraindications

None known.  

Side Effects

Occasionally, mild gastrointestinal upsets.  

Interactions with Other Drugs

None known.  

Dosage

Unless otherwise prescribed:

Daily dose:

  • 4 - 6 g of drug;
  • equivalent preparations.  

Mode of Administration

Comminuted drug for infusions as well as other galenical preparations for oral use.  

Actions

Increase of urinary volume
Increase of maximum urinary flow
Reduction of residual urine

Note:This drug only relieves the symptoms of an enlarged prostate without reducing the enlargement.  Please consult a physician at regular intervals.